Skip to main content
Livermore
Livermore
ZHEN

Macquarie Group Ltd

SEC CIK
0001418333
Latest filing
Aug 14, 2026

CYTK holding history

Cytokinetics Inc in every 13F filed by Macquarie Group Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CYTK overviewAll 13F holders of CYTKFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of CYTK by Macquarie Group Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−110,260−100.0%Sold outHolders
Q3 2025110,260$6.06M<0.1%+26,388+31.5%AddedHolders
Q2 202583,872$2.77M<0.1%+9,466+12.7%AddedHolders
Q1 202574,406$2.99M<0.1%−1,027−1.4%ReducedHolders
Q4 202475,433$3.55M<0.1%+1,533+2.1%AddedHolders
Q3 202473,900$3.90M<0.1%+301+0.4%AddedHolders
Q2 202473,599$3.99M<0.1%−27,445−27.2%ReducedHolders
Q1 2024101,044$7.08M<0.1%+59,060+140.7%AddedHolders
Q4 202341,984$3.50M<0.1%−5,775−12.1%ReducedHolders
Q3 202347,759$1.41M<0.1%+9,059+23.4%AddedHolders
Q2 202338,700$1.26M<0.1%+2,276+6.2%AddedHolders
Q1 202336,424$1.28M<0.1%−37,236−50.6%ReducedHolders
Q4 202273,660$3.38M<0.1%−40,645−35.6%ReducedHolders
Q3 2022114,305$5.58M<0.1%+34,847+43.9%AddedHolders
Q2 202279,458$3.12M<0.1%+28,156+54.9%AddedHolders
Q1 202251,302$1.89M<0.1%+5,655+12.4%AddedHolders
Q4 202145,647$2.08M<0.1%−15,316−25.1%ReducedHolders
Q3 202160,963$2.18M<0.1%−13,636−18.3%ReducedHolders
Q2 202174,599$1.48M<0.1%−160−0.2%ReducedHolders
Q1 202174,759$1.74M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.